Medical Care

Global In-Vitro Toxicology and Toxicity Testing Market Research Report 2025

The global market for In-Vitro Toxicology and Toxicity Testing was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
North American market for In-Vitro Toxicology and Toxicity Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for In-Vitro Toxicology and Toxicity Testing is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for In-Vitro Toxicology and Toxicity Testing in Pharmaceutical Industry is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of In-Vitro Toxicology and Toxicity Testing include GE Healthcare, Thermo Fisher Scientific, Bio-Rad Laboratories, Agilent Technologies, Cyprotex, Covance, Bioreliance, Catalent, Charles River Laboratories International, Alere, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for In-Vitro Toxicology and Toxicity Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Toxicology and Toxicity Testing.
The In-Vitro Toxicology and Toxicity Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In-Vitro Toxicology and Toxicity Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the In-Vitro Toxicology and Toxicity Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GE Healthcare
Thermo Fisher Scientific
Bio-Rad Laboratories
Agilent Technologies
Cyprotex
Covance
Bioreliance
Catalent
Charles River Laboratories International
Alere
Eurofins Scientific
Life Technologies Corporation
Quest Diagnostics
Segment by Type
Cell Culture Technology
High Throughput Technologies
Molecular Imaging Technologies
Omics Technologies
Segment by Application
Pharmaceutical Industry
Chemical Industry
Food Industry
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of In-Vitro Toxicology and Toxicity Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Cell Culture Technology
1.2.3 High Throughput Technologies
1.2.4 Molecular Imaging Technologies
1.2.5 Omics Technologies
1.3 Market by Application
1.3.1 Global In-Vitro Toxicology and Toxicity Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Industry
1.3.3 Chemical Industry
1.3.4 Food Industry
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global In-Vitro Toxicology and Toxicity Testing Market Perspective (2020-2031)
2.2 Global In-Vitro Toxicology and Toxicity Testing Growth Trends by Region
2.2.1 Global In-Vitro Toxicology and Toxicity Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 In-Vitro Toxicology and Toxicity Testing Historic Market Size by Region (2020-2025)
2.2.3 In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Region (2026-2031)
2.3 In-Vitro Toxicology and Toxicity Testing Market Dynamics
2.3.1 In-Vitro Toxicology and Toxicity Testing Industry Trends
2.3.2 In-Vitro Toxicology and Toxicity Testing Market Drivers
2.3.3 In-Vitro Toxicology and Toxicity Testing Market Challenges
2.3.4 In-Vitro Toxicology and Toxicity Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue
3.1.1 Global Top In-Vitro Toxicology and Toxicity Testing Players by Revenue (2020-2025)
3.1.2 Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Players (2020-2025)
3.2 Global In-Vitro Toxicology and Toxicity Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by In-Vitro Toxicology and Toxicity Testing Revenue
3.4 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio
3.4.1 Global In-Vitro Toxicology and Toxicity Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by In-Vitro Toxicology and Toxicity Testing Revenue in 2024
3.5 Global Key Players of In-Vitro Toxicology and Toxicity Testing Head office and Area Served
3.6 Global Key Players of In-Vitro Toxicology and Toxicity Testing, Product and Application
3.7 Global Key Players of In-Vitro Toxicology and Toxicity Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 In-Vitro Toxicology and Toxicity Testing Breakdown Data by Type
4.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size by Type (2020-2025)
4.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Type (2026-2031)
5 In-Vitro Toxicology and Toxicity Testing Breakdown Data by Application
5.1 Global In-Vitro Toxicology and Toxicity Testing Historic Market Size by Application (2020-2025)
5.2 Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America In-Vitro Toxicology and Toxicity Testing Market Size (2020-2031)
6.2 North America In-Vitro Toxicology and Toxicity Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2020-2025)
6.4 North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe In-Vitro Toxicology and Toxicity Testing Market Size (2020-2031)
7.2 Europe In-Vitro Toxicology and Toxicity Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2020-2025)
7.4 Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size (2020-2031)
8.2 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America In-Vitro Toxicology and Toxicity Testing Market Size (2020-2031)
9.2 Latin America In-Vitro Toxicology and Toxicity Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2020-2025)
9.4 Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size (2020-2031)
10.2 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GE Healthcare
11.1.1 GE Healthcare Company Details
11.1.2 GE Healthcare Business Overview
11.1.3 GE Healthcare In-Vitro Toxicology and Toxicity Testing Introduction
11.1.4 GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.1.5 GE Healthcare Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 Bio-Rad Laboratories
11.3.1 Bio-Rad Laboratories Company Details
11.3.2 Bio-Rad Laboratories Business Overview
11.3.3 Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Introduction
11.3.4 Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.3.5 Bio-Rad Laboratories Recent Development
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Details
11.4.2 Agilent Technologies Business Overview
11.4.3 Agilent Technologies In-Vitro Toxicology and Toxicity Testing Introduction
11.4.4 Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.4.5 Agilent Technologies Recent Development
11.5 Cyprotex
11.5.1 Cyprotex Company Details
11.5.2 Cyprotex Business Overview
11.5.3 Cyprotex In-Vitro Toxicology and Toxicity Testing Introduction
11.5.4 Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.5.5 Cyprotex Recent Development
11.6 Covance
11.6.1 Covance Company Details
11.6.2 Covance Business Overview
11.6.3 Covance In-Vitro Toxicology and Toxicity Testing Introduction
11.6.4 Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.6.5 Covance Recent Development
11.7 Bioreliance
11.7.1 Bioreliance Company Details
11.7.2 Bioreliance Business Overview
11.7.3 Bioreliance In-Vitro Toxicology and Toxicity Testing Introduction
11.7.4 Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.7.5 Bioreliance Recent Development
11.8 Catalent
11.8.1 Catalent Company Details
11.8.2 Catalent Business Overview
11.8.3 Catalent In-Vitro Toxicology and Toxicity Testing Introduction
11.8.4 Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.8.5 Catalent Recent Development
11.9 Charles River Laboratories International
11.9.1 Charles River Laboratories International Company Details
11.9.2 Charles River Laboratories International Business Overview
11.9.3 Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Introduction
11.9.4 Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.9.5 Charles River Laboratories International Recent Development
11.10 Alere
11.10.1 Alere Company Details
11.10.2 Alere Business Overview
11.10.3 Alere In-Vitro Toxicology and Toxicity Testing Introduction
11.10.4 Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.10.5 Alere Recent Development
11.11 Eurofins Scientific
11.11.1 Eurofins Scientific Company Details
11.11.2 Eurofins Scientific Business Overview
11.11.3 Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Introduction
11.11.4 Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.11.5 Eurofins Scientific Recent Development
11.12 Life Technologies Corporation
11.12.1 Life Technologies Corporation Company Details
11.12.2 Life Technologies Corporation Business Overview
11.12.3 Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Introduction
11.12.4 Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.12.5 Life Technologies Corporation Recent Development
11.13 Quest Diagnostics
11.13.1 Quest Diagnostics Company Details
11.13.2 Quest Diagnostics Business Overview
11.13.3 Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Introduction
11.13.4 Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
11.13.5 Quest Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Cell Culture Technology
Table 3. Key Players of High Throughput Technologies
Table 4. Key Players of Molecular Imaging Technologies
Table 5. Key Players of Omics Technologies
Table 6. Global In-Vitro Toxicology and Toxicity Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global In-Vitro Toxicology and Toxicity Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global In-Vitro Toxicology and Toxicity Testing Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global In-Vitro Toxicology and Toxicity Testing Market Share by Region (2020-2025)
Table 10. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global In-Vitro Toxicology and Toxicity Testing Market Share by Region (2026-2031)
Table 12. In-Vitro Toxicology and Toxicity Testing Market Trends
Table 13. In-Vitro Toxicology and Toxicity Testing Market Drivers
Table 14. In-Vitro Toxicology and Toxicity Testing Market Challenges
Table 15. In-Vitro Toxicology and Toxicity Testing Market Restraints
Table 16. Global In-Vitro Toxicology and Toxicity Testing Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global In-Vitro Toxicology and Toxicity Testing Market Share by Players (2020-2025)
Table 18. Global Top In-Vitro Toxicology and Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Toxicology and Toxicity Testing as of 2024)
Table 19. Ranking of Global Top In-Vitro Toxicology and Toxicity Testing Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by In-Vitro Toxicology and Toxicity Testing Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of In-Vitro Toxicology and Toxicity Testing, Headquarters and Area Served
Table 22. Global Key Players of In-Vitro Toxicology and Toxicity Testing, Product and Application
Table 23. Global Key Players of In-Vitro Toxicology and Toxicity Testing, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global In-Vitro Toxicology and Toxicity Testing Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2020-2025)
Table 27. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Type (2026-2031)
Table 29. Global In-Vitro Toxicology and Toxicity Testing Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Application (2020-2025)
Table 31. Global In-Vitro Toxicology and Toxicity Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global In-Vitro Toxicology and Toxicity Testing Revenue Market Share by Application (2026-2031)
Table 33. North America In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe In-Vitro Toxicology and Toxicity Testing Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America In-Vitro Toxicology and Toxicity Testing Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size by Country (2026-2031) & (US$ Million)
Table 48. GE Healthcare Company Details
Table 49. GE Healthcare Business Overview
Table 50. GE Healthcare In-Vitro Toxicology and Toxicity Testing Product
Table 51. GE Healthcare Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 52. GE Healthcare Recent Development
Table 53. Thermo Fisher Scientific Company Details
Table 54. Thermo Fisher Scientific Business Overview
Table 55. Thermo Fisher Scientific In-Vitro Toxicology and Toxicity Testing Product
Table 56. Thermo Fisher Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 57. Thermo Fisher Scientific Recent Development
Table 58. Bio-Rad Laboratories Company Details
Table 59. Bio-Rad Laboratories Business Overview
Table 60. Bio-Rad Laboratories In-Vitro Toxicology and Toxicity Testing Product
Table 61. Bio-Rad Laboratories Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 62. Bio-Rad Laboratories Recent Development
Table 63. Agilent Technologies Company Details
Table 64. Agilent Technologies Business Overview
Table 65. Agilent Technologies In-Vitro Toxicology and Toxicity Testing Product
Table 66. Agilent Technologies Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 67. Agilent Technologies Recent Development
Table 68. Cyprotex Company Details
Table 69. Cyprotex Business Overview
Table 70. Cyprotex In-Vitro Toxicology and Toxicity Testing Product
Table 71. Cyprotex Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 72. Cyprotex Recent Development
Table 73. Covance Company Details
Table 74. Covance Business Overview
Table 75. Covance In-Vitro Toxicology and Toxicity Testing Product
Table 76. Covance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 77. Covance Recent Development
Table 78. Bioreliance Company Details
Table 79. Bioreliance Business Overview
Table 80. Bioreliance In-Vitro Toxicology and Toxicity Testing Product
Table 81. Bioreliance Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 82. Bioreliance Recent Development
Table 83. Catalent Company Details
Table 84. Catalent Business Overview
Table 85. Catalent In-Vitro Toxicology and Toxicity Testing Product
Table 86. Catalent Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 87. Catalent Recent Development
Table 88. Charles River Laboratories International Company Details
Table 89. Charles River Laboratories International Business Overview
Table 90. Charles River Laboratories International In-Vitro Toxicology and Toxicity Testing Product
Table 91. Charles River Laboratories International Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 92. Charles River Laboratories International Recent Development
Table 93. Alere Company Details
Table 94. Alere Business Overview
Table 95. Alere In-Vitro Toxicology and Toxicity Testing Product
Table 96. Alere Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 97. Alere Recent Development
Table 98. Eurofins Scientific Company Details
Table 99. Eurofins Scientific Business Overview
Table 100. Eurofins Scientific In-Vitro Toxicology and Toxicity Testing Product
Table 101. Eurofins Scientific Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 102. Eurofins Scientific Recent Development
Table 103. Life Technologies Corporation Company Details
Table 104. Life Technologies Corporation Business Overview
Table 105. Life Technologies Corporation In-Vitro Toxicology and Toxicity Testing Product
Table 106. Life Technologies Corporation Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 107. Life Technologies Corporation Recent Development
Table 108. Quest Diagnostics Company Details
Table 109. Quest Diagnostics Business Overview
Table 110. Quest Diagnostics In-Vitro Toxicology and Toxicity Testing Product
Table 111. Quest Diagnostics Revenue in In-Vitro Toxicology and Toxicity Testing Business (2020-2025) & (US$ Million)
Table 112. Quest Diagnostics Recent Development
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report


List of Figures
Figure 1. In-Vitro Toxicology and Toxicity Testing Picture
Figure 2. Global In-Vitro Toxicology and Toxicity Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global In-Vitro Toxicology and Toxicity Testing Market Share by Type: 2024 VS 2031
Figure 4. Cell Culture Technology Features
Figure 5. High Throughput Technologies Features
Figure 6. Molecular Imaging Technologies Features
Figure 7. Omics Technologies Features
Figure 8. Global In-Vitro Toxicology and Toxicity Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global In-Vitro Toxicology and Toxicity Testing Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical Industry Case Studies
Figure 11. Chemical Industry Case Studies
Figure 12. Food Industry Case Studies
Figure 13. Other Case Studies
Figure 14. In-Vitro Toxicology and Toxicity Testing Report Years Considered
Figure 15. Global In-Vitro Toxicology and Toxicity Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global In-Vitro Toxicology and Toxicity Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global In-Vitro Toxicology and Toxicity Testing Market Share by Region: 2024 VS 2031
Figure 18. Global In-Vitro Toxicology and Toxicity Testing Market Share by Players in 2024
Figure 19. Global Top In-Vitro Toxicology and Toxicity Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in In-Vitro Toxicology and Toxicity Testing as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by In-Vitro Toxicology and Toxicity Testing Revenue in 2024
Figure 21. North America In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America In-Vitro Toxicology and Toxicity Testing Market Share by Country (2020-2031)
Figure 23. United States In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe In-Vitro Toxicology and Toxicity Testing Market Share by Country (2020-2031)
Figure 27. Germany In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific In-Vitro Toxicology and Toxicity Testing Market Share by Region (2020-2031)
Figure 35. China In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America In-Vitro Toxicology and Toxicity Testing Market Share by Country (2020-2031)
Figure 43. Mexico In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa In-Vitro Toxicology and Toxicity Testing Market Share by Country (2020-2031)
Figure 47. Turkey In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE In-Vitro Toxicology and Toxicity Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. GE Healthcare Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 52. Bio-Rad Laboratories Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 53. Agilent Technologies Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 54. Cyprotex Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 55. Covance Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 56. Bioreliance Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 57. Catalent Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 58. Charles River Laboratories International Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 59. Alere Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 60. Eurofins Scientific Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 61. Life Technologies Corporation Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 62. Quest Diagnostics Revenue Growth Rate in In-Vitro Toxicology and Toxicity Testing Business (2020-2025)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies